Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.

PLoS One · 2018 · PMC6101361 · PMID 30125285

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

administrations anti-ß 1 EC2–titers tended to decrease in response to therapy with COR-1 compared to the titers at initation of therapy, but this trend did not reach statistical significance at any dosing.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.